Department of Thoracic Medicine, The Prince Charles Hospital, University of Queensland Thoracic Research Centre, Brisbane, Australia.
Cancer Research And Biostatistics (CRAB), Seattle, Washington.
J Thorac Oncol. 2024 May;19(5):786-802. doi: 10.1016/j.jtho.2024.01.019. Epub 2024 Feb 4.
This study analyzed all metastatic categories of the current TNM classification of NSCLC to propose modifications of the M component in the next edition (ninth) of the classification.
A database of 124,581 patients diagnosed between 2011 and 2019 was established; of these, 14,937 with NSCLC in stages IVA to IVB were available for this analysis. Overall survival was calculated using the Kaplan-Meier method, and prognosis was assessed using multivariable-adjusted Cox proportional hazards regression.
The eighth edition M categories revealed good discrimination in the ninth edition data set. Assessments revealed that an increasing number of metastatic lesions were associated with decreasing prognosis; because this seems to be a continuum and adjustment for confounders was not possible, no specific lesion number was deemed appropriate for stage classification. Among tumors involving multiple metastases, decreasing prognosis was found with an increasing number of organ systems involved. Multiple assessments, including after adjustment for potential confounders, revealed that M1c patients who had metastases to a single extrathoracic organ system were prognostically distinct from M1c patients who had involvement of multiple extrathoracic organ systems.
These data validate the eighth edition M1a and M1b categories, which are recommended to be maintained. We propose the M1c category be divided into M1c1 (involvement of a single extrathoracic organ system) and M1c2 (involvement of multiple extrathoracic organ systems).
本研究分析了 NSCLC 现行 TNM 分类的所有转移类别,旨在为分类的下一个(第九版)版本修改 M 成分。
建立了一个包含 124581 名患者的数据库,这些患者在 2011 年至 2019 年间被诊断为 NSCLC,其中 14937 名患者处于 IVA 期至 IVB 期,可用于本分析。使用 Kaplan-Meier 方法计算总生存率,并使用多变量调整 Cox 比例风险回归评估预后。
第八版 M 类别在第九版数据集显示出良好的区分度。评估显示,转移病灶数量的增加与预后的降低相关;由于这似乎是一个连续体,且调整混杂因素是不可能的,因此没有为分期分类选择特定的病灶数量。在涉及多个转移的肿瘤中,随着受累器官系统数量的增加,预后呈下降趋势。多项评估,包括在调整潜在混杂因素后,发现转移到单个胸外器官系统的 M1c 患者与转移到多个胸外器官系统的 M1c 患者在预后上有显著区别。
这些数据验证了第八版 M1a 和 M1b 类别,建议将其保留。我们建议将 M1c 类别分为 M1c1(涉及单个胸外器官系统)和 M1c2(涉及多个胸外器官系统)。